世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
WORLD JOURNAL OF TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
3期
294-296
,共3页
胡兵%安红梅%李刚%杜琴%沈克平%许玲%魏蒙蒙%王双双
鬍兵%安紅梅%李剛%杜琴%瀋剋平%許玲%魏矇矇%王雙雙
호병%안홍매%리강%두금%침극평%허령%위몽몽%왕쌍쌍
大肠癌%藤龙补中汤%调节性T细胞%IL-10%TGF-β
大腸癌%籐龍補中湯%調節性T細胞%IL-10%TGF-β
대장암%등룡보중탕%조절성T세포%IL-10%TGF-β
Colorectal Cancer%Tenglong Buzhong Decoction%Regulatory T Cells%IL-1 0%TGF-β
目的:大肠癌是全球常见恶性肿瘤;调节性T细胞(Regulatory T cells,Tregs)是一群免疫负调控细胞,参与大肠癌的发病,与大肠癌预后直接相关。藤龙补中汤是以解毒健脾立法的中药复方,细胞与动物模型研究显示藤龙补中汤可以促大肠癌细胞凋亡、细胞衰老,增强化疗对大肠癌的疗效。本研究观察了藤龙补中汤对晚期大肠癌患者Tregs的作用。方法晚期大肠癌患者随机分为对照组及治疗组,分别给化疗或藤龙补中汤联合化疗治疗;观察患者治疗前后Tregs细胞及相关细胞因子变化。流式细胞仪检测 Tregs 细胞,酶联免疫吸附实验(Enzyme -Linked Immunosorbent Assay, ELISA)检测细胞因子。结果治疗组治疗后调节性T细胞及白介素-10(Interleukin-10,IL-10)、转化生长因子-β(Transforming growth factor-β,TGF-β)水平显著降低(P<0.01),与对照组比较差异显著(P<0.01)。结论藤龙补中汤可以降低晚期大肠癌患者Tregs细胞数量,以相关细胞因子IL-10、TGF-β水平。
目的:大腸癌是全毬常見噁性腫瘤;調節性T細胞(Regulatory T cells,Tregs)是一群免疫負調控細胞,參與大腸癌的髮病,與大腸癌預後直接相關。籐龍補中湯是以解毒健脾立法的中藥複方,細胞與動物模型研究顯示籐龍補中湯可以促大腸癌細胞凋亡、細胞衰老,增彊化療對大腸癌的療效。本研究觀察瞭籐龍補中湯對晚期大腸癌患者Tregs的作用。方法晚期大腸癌患者隨機分為對照組及治療組,分彆給化療或籐龍補中湯聯閤化療治療;觀察患者治療前後Tregs細胞及相關細胞因子變化。流式細胞儀檢測 Tregs 細胞,酶聯免疫吸附實驗(Enzyme -Linked Immunosorbent Assay, ELISA)檢測細胞因子。結果治療組治療後調節性T細胞及白介素-10(Interleukin-10,IL-10)、轉化生長因子-β(Transforming growth factor-β,TGF-β)水平顯著降低(P<0.01),與對照組比較差異顯著(P<0.01)。結論籐龍補中湯可以降低晚期大腸癌患者Tregs細胞數量,以相關細胞因子IL-10、TGF-β水平。
목적:대장암시전구상견악성종류;조절성T세포(Regulatory T cells,Tregs)시일군면역부조공세포,삼여대장암적발병,여대장암예후직접상관。등룡보중탕시이해독건비입법적중약복방,세포여동물모형연구현시등룡보중탕가이촉대장암세포조망、세포쇠로,증강화료대대장암적료효。본연구관찰료등룡보중탕대만기대장암환자Tregs적작용。방법만기대장암환자수궤분위대조조급치료조,분별급화료혹등룡보중탕연합화료치료;관찰환자치료전후Tregs세포급상관세포인자변화。류식세포의검측 Tregs 세포,매련면역흡부실험(Enzyme -Linked Immunosorbent Assay, ELISA)검측세포인자。결과치료조치료후조절성T세포급백개소-10(Interleukin-10,IL-10)、전화생장인자-β(Transforming growth factor-β,TGF-β)수평현저강저(P<0.01),여대조조비교차이현저(P<0.01)。결론등룡보중탕가이강저만기대장암환자Tregs세포수량,이상관세포인자IL-10、TGF-β수평。
Objective Colorectal cancer is the common malignant tumor in the world.The regulatory T cells(Tregs)are the group of immune negative regulatory cells,involved in the occurrence of colorectal cancer and closely related to the prognosis of colorectal cancer.Tenglong Buzhong Decoction is the compound Chinese medicine for removing toxin and strengthening the spleen.The cell and animal model study showed that Tenglong Buzhong Decoction promoted colorectal cancer cell apoptosis and call aging and enhanced the effect of chemotherapy for colorectal cancer.The study observed the effect of Tenglong Buzhong Decoction on Tregs in the patients of late colorectal cancer.Methods The patients of late colorectal cancer were random-ized into a control group and a treatment group,treated with chemotherapy or the combined therapy of Ten-glong Buzhong Decoction and chemotherapy(combined therapy)separately.Tregs and the relevant cytokines were observed before and after treatment in the treatment.Flow cytometry(FCM)was used to detect Tregs. Enzyme-linked immunosorbent assay(ELISA)was to detect cytokines.Results In the treatment group,the levels of Tregs,interleukin-1 0(IL-1 0)and transforming growth factor-β(TGF-β)were reduced signifi-cantly after treatment(P<0.01 )and were different significantly as compared with those in the control group (P<0.01 ).Conclusion Tenglong Buzhong Decoction reduces the count of Tregs and the levels of IL-1 0 and TGF-βin the patients of late colorectal cancer.